US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Geron Corporation - Common Stock
(NQ:
GERN
)
0.8944
-0.0518 (-5.47%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Geron Corporation - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights
May 10, 2021
From
Geron Corporation
Via
Business Wire
Earnings Scheduled For May 10, 2021
↗
May 10, 2021
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...
Via
Benzinga
Geron to Announce First Quarter 2021 Financial Results on May 10, 2021
May 03, 2021
From
Geron Corporation
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
April 23, 2021
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 11.8% to $1.61 during Friday's pre-market session. The market value of their outstanding shares is at $205....
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
↗
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 22, 2021
From
Geron Corporation
Via
Business Wire
Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 - Kehoe Law Firm, P.C. Investigation
April 20, 2021
Investigation To Determine Whether Certain Officers And/Or Directors Of Geron Corporation Breached Their Fiduciary Duties
Via
EIN Presswire
Topics
Fraud
Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis
April 13, 2021
From
Geron Corporation
Via
Business Wire
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
